Webinars: Past and Upcoming

Five principles have been recognised as part of the next phase of the COVID-19 response- Nothing about us without us. One of these key principles is Make everyone matter, leave no-one behind.

Healthcare systems focus on achieving measurable targets such as blood pressure, total cholesterol, HbA1c and albumin creatinine ratio. These figures however mean little to a person living with diabetes, who are more concerned about the risk retinopathy, amputation and heart failure.

This joint session with people living with diabetes, patient advocates and healthcare practitioners will focus on agreeing personal goals and how these may be achieved

• Dr David Strain (chair)
• Prof Partha Kar – National Specialist Advisor, Diabetes, NHS England
• Maggie Meer, DPC Founder 
• Christine Douglas , Expert in patient liaison 
• Alison Cox, Diabetes Specialist Nurse 
• Dr Roni Saha, Consultant in acute medicine,  Diabetes & Endocrinology

 

Kindly supported by: 

This independent programme has been funded by AstraZeneca. AstraZeneca has had no editorial input into, or control over the content. DPC is responsible for the content of all materials and selection of speakers pertaining to this educational series

When considering the management of diabetes, it is important to recognise that the person living with diabetes is living with a complex long-term condition involving monitoring diet, reviewing exercise targets and ensuring adherence to multiple medications on a daily basis. A focus on achieving glycaemic, blood pressure and lipid targets has the potential to lose the person at the centre, replacing them with a “patient” and targets.

• Dr David Strain (chair)
• Prof Partha Kar – National Specialist Advisor, Diabetes, NHS England
• Maggie Meer, DPC Founder 
• Christine Douglas , Expert in patient liaison 
• Alison Cox, Diabetes Specialist Nurse 
• Dr Jim Moore GP and GPSI Cardiology President, Primary Care Cardiovascular Society

 

Kindly supported by: 

This independent programme has been funded by AstraZeneca. AstraZeneca has had no editorial input into, or control over the content. DPC is responsible for the content of all materials and selection of speakers pertaining to this educational series

The panel will focus on accelerating the return to near-normal levels of non-Covid health services, making full use of the capacity available in the ‘window of opportunity’ between now and winter

• Prof Partha Kar – National Specialist Advisor, Diabetes, NHS England
• Dr David Strain (chair) Clinical Senior Lecturer,  Diabetes and Vascular Research Centre
• Dr Jim Moore GP and GPSI Cardiology President, Primary Care Cardiovascular Society
• Prof Ahmet Fuat, GPSI Cardiology & Professor of Primary Care Cardiology
• Dr. Marc Evans Consultant Diabetologist
• Debbie Hicks Nurse Consultant – Diabetes, Medicus Health Partners

 

Kindly supported by: 

This independent programme has been funded by AstraZeneca. AstraZeneca has had no editorial input into, or control over the content. DPC is responsible for the content of all materials and selection of speakers pertaining to this educational series

Our panel answered your questions relating to Long Covid and Kidney Health

• Dr David Strain (chair) Clinical Senior Lecturer,  Diabetes and Vascular Research Centre
• Prof June James, Honorary Associate Professor
• Dr Dush Mital – Consultant, Blood Borne Viruses
• Prof James Burton, Professor of Renal Medicine & Honorary Consultant Nephrologist

This session will examine the impact of Covid-19 on some people has led to Diabetes like symptoms including on the heart, respiratory system, and cognitive function. Our panel will examine the most up to date case studies.

• Prof Partha Kar – National Specialist Advisor, Diabetes, NHS England
• Dr David Strain (chair)
• Su Down – Nurse Consultant Diabetes
• Dr Dush Mital – Consultant, Blood Borne Viruses
• Claire Fuller – Patient Speaker

Key learning outcomes:
 

• Renal impairment is the single strongest predictor of vascular disease
• The importance of regular evaluation
• eGFR and microalbuminuria
• Modifications to treatment strategies to prevent vascular disease progression

 

Speakers: 

• Dr David Strain, Clinical Senior Lecturer,  Diabetes and Vascular Research Centre
• Prof June James, Honorary Associate Professor
• Dr Kevin Fernando, GP Partner & Medical Education & Scottish Lead
• Dr Sarah Davies  GP Partner
• Prof Steve Bain, Clinical Director of the Diabetes Research Unit
• Prof James Burton, Professor of Renal Medicine & Honorary Consultant Nephrologist
• Hannah Beba, Senior Pharmacist Diabetes and Endocrinology

Key learning outcomes:

• What GFR means, how can we estimate it
• Prevention
• Modification of glycaemic treatment strategies
  • Metformin, SUs, DPP-4i, SGLT-2s, Insulin and GLP-1
• The Use of ACE inhibitors and other agents
• Delaying renal disease progression
   

Speakers: 

• Dr David Strain Clinical Senior Lecturer,  Diabetes and Vascular Research Centre
• Dr Andrew Frankel Consultant renal physician 
• Prof Steve Bain Clinical Director of the Diabetes Research Unit
• Dr Sarah Davies GP Partner
• Dr Kevin Fernando GP Partner & Medical Education & Scottish Lead

 

Napp Pharmaceuticals Limited are sponsors of the DPC Diabetes Renal Webinar Series and have had no involvement in the organisation of this meeting, the educational content or selection of speakers.

The DPC Summer Forum - ADA into practice has deciphered the main outcomes from the ADA Scientific Conference. As we had so many questions asked during the ADA into Practice webinars that we have decided to run an extra webinar to answer them!

MDT Panel:

• Dr. David Strain (Chair) Clinical Senior Lecturer, Diabetes and Vascular Research Centre
• Amanda Epps Diabetes Specialist Nurse
• Dr. Marc Evans Consultant Diabetologist
• Hannah Beba Senior Pharmacist Diabetes and Endocrinology
• Dr. Kevin Fernando GP Partner & Medical Education & Scottish Lead
• Dr Jim Moore GP and GPSI Cardiology President, Primary Care Cardiovascular Society

Hyperkalaemia is a common diagnosis. Fortunately, most patients who are diagnosed have mild hyperkalemia (which is usually well tolerated). However, any condition causing even mild hyperkalemia should be treated to prevent progression into more severe hyperkalemia. Many drugs commonly used in diabetes as well as the associated impaired renal function that often accompanies predispose towards elevated potassium.

Speakers

• Dr David Strain, Clinical Senior Lecturer, Diabetes and Vascular Research Centre
• June James, Nurse Consultant Diabetes, Associate Professor
• Louise Clayton, Advanced Nurse Practitioner
• Prof Ahmet Fuat, GPSI Cardiology & Professor of Primary Care Cardiology
• Ketan Kavia, Pharmacist Advanced Clinical Practitioner

This live webinar will cover key take-home messages from the recent virtual ADA 2020 congress focusing on the ground-breaking DAPA-HF study – the first positive SGLT2 inhibitor study with dedicated heart failure outcomes.  Our expert diabetes multidisciplinary panel spanning primary and secondary care will distil their main learning points from DAPA-HF as well as discussing how this learning might be implemented into day-to-day clinical practice

Speakers

• Dr. David Strain (chair) Clinical Senior Lecturer, Diabetes and Vascular Research Centre
• Prof John McMurray Professor of Cardiology, Lead Author DAPA-HF
• Dr. Marc Evans Consultant Diabetologist
• Dr. Jim Moore GP and GPSI Cardiology President, Primary Care Cardiovascular Society
• Philip Newland-Jones Consultant Pharmacist Diabetes & Endocrinology Clinical Director Diabetes & Endocrinology
• Amanda Epps Diabetes Specialist Nurse
• Dr. Kevin Fernando  GP Partner & Medical Education & Scottish Lead

This live webinar will cover key take-home messages from the recent virtual ADA 2020 congress focusing on the GLP1 receptor agonist class of antihyperglycaemic medication.  Our expert diabetes multidisciplinary panel spanning primary and secondary care will distil their main learning points from key ADA2020 GLP1RA sessions as well as discussing how this learning might be implemented into day-to-day clinical practice

Panel

• Dr. David Strain (chair) Clinical Senior Lecturer, Diabetes and Vascular Research Centre
• Dr. Patrick Holmes GPwSI
• Debbie Hicks Nurse Consultant – Diabetes, Medicus Health Partners, Co-Chair
• Dr. Marc Evans Consultant Diabetologist
• Victoria Ruszala Specialist Diabetes and Endocrine Pharmacist 

This live webinar will covered key take-home messages from the recent virtual ADA 2020 congress focusing on the latest SGLT2 inhibitor CV outcomes trial VERTIS CV (ertugliflozin) – are the benefits of SGLT2 inhibitors a class effect?  Our expert diabetes multidisciplinary panel, spanning primary and secondary care, distil their main learning points from VERTIS-CV as well as discussing how this learning might be implemented into day-to-day clinical practice.

PANEL:

• Dr. David Strain Clinical Senior Lecturer, Diabetes and Vascular Research Centre
• Dr Derek Connnolly – Consultant Interventional Cardiologist
• Dr Jim Moore GP and GPSI Cardiology President, Primary Care Cardiovascular Society
• Dr. Marc Evans Consultant Diabetologist
• Debbie Hicks Nurse Consultant – Diabetes, Medicus Health Partners, Co-Chair
• Dr Patrick Holmes GPwSI Diabetes
• Hannah Beba Senior Pharmacist Diabetes and Endocrinology

This live webinar covered key take-home messages from the recent virtual ADA 2020 congress to help improve care for people living with diabetes.  Our expert diabetes multidisciplinary panel spanning primary and secondary care will distilled their main learning points from the congress as well as discussing how this learning might be implemented into day-to-day clinical practice. 

MDT Panel

• Dr. Kevin Fernando (Chair) GP Partner & Medical Education & Scottish Lead
• Dr. David Strain Clinical Senior Lecturer, Diabetes and Vascular Research Centre
• Dr. Patrick Holmes GPwSI Diabetes
• Debbie Hicks Nurse Consultant – Diabetes, Medicus Health Partners, Co-Chair
• Philip Newland-Jones Consultant Pharmacist Diabetes & Endocrinology Clinical Director Diabetes & Endocrinology

During Mental Health Week, Diabetes Professional Care will host a webinar focusing on psychological consequences of COVID-19 for people with diabetes. Since the lockdown, professionals working in diabetes are increasingly using virtual technology to consult with their patients. We will discuss the benefits and challenges of this new way of working, which is certain to continue as an important option for connecting with people in the future.

Living in enforced isolation may have consequences of particular importance for people with diabetes, especially those prone to anxiety or depression. We will hear the stories of the diabetes community and their thoughts of how to adapt to life after COVID.